Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Characterization of Endocannabinoid-Metabolizing Enzymes in Human Peripheral Blood Mononuclear Cells under Inflammatory Conditions.

Szafran BN, Lee JH, Borazjani A, Morrison P, Zimmerman G, Andrzejewski KL, Ross MK, Kaplan BLF.

Molecules. 2018 Dec 1;23(12). pii: E3167. doi: 10.3390/molecules23123167.

2.

Effect of repeated juvenile exposure to Δ9‑tetrahydrocannabinol on anxiety-related behavior and social interactions in adolescent rats.

Mohammed AN, Alugubelly N, Kaplan BL, Carr RL.

Neurotoxicol Teratol. 2018 Sep - Oct;69:11-20. doi: 10.1016/j.ntt.2018.06.003. Epub 2018 Jun 21.

PMID:
29936119
3.

Evaluation of Marijuana Compounds on Neuroimmune Endpoints in Experimental Autoimmune Encephalomyelitis.

Kaplan BLF.

Curr Protoc Toxicol. 2018 Feb 21;75:11.25.1-11.25.22. doi: 10.1002/cptx.43.

PMID:
29512125
4.

CLARITY-BPA: Effects of chronic Bisphenol A exposure on the immune system: Part 1 - Quantification of the relative number and proportion of leukocyte populations in the spleen and thymus.

Li J, Bach A, Crawford RB, Phadnis-Moghe AS, Chen W, D'Ingillo S, Kovalova N, Suarez-Martinez JE, Zhou J, Kaplan BLF, Kaminski NE.

Toxicology. 2018 Mar 1;396-397:46-53. doi: 10.1016/j.tox.2018.01.004. Epub 2018 Feb 8.

5.

CLARITY-BPA: Effects of chronic bisphenol A exposure on the immune system: Part 2 - Characterization of lymphoproliferative and immune effector responses by splenic leukocytes.

Li J, Bach A, Crawford RB, Phadnis-Moghe AS, Chen W, D'Ingillo S, Kovalova N, Suarez-Martinez JE, Zhou J, Kaplan BLF, Kaminski NE.

Toxicology. 2018 Mar 1;396-397:54-67. doi: 10.1016/j.tox.2018.02.004. Epub 2018 Feb 7.

6.

Endocannabinoid engagement of CB2 regulates RSV-induced immunity.

Kaplan BLF.

Virulence. 2018 Jan 1;9(1):494-495. doi: 10.1080/21505594.2017.1421830. No abstract available.

PMID:
29338583
7.

Induction of Immunosuppressive CD8+CD25+FOXP3+ Regulatory T Cells by Suboptimal Stimulation with Staphylococcal Enterotoxin C1.

Lee J, Park N, Park JY, Kaplan BLF, Pruett SB, Park JW, Park YH, Seo KS.

J Immunol. 2018 Jan 15;200(2):669-680. doi: 10.4049/jimmunol.1602109. Epub 2017 Dec 13.

8.

Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.

Dhital S, Stokes JV, Park N, Seo KS, Kaplan BL.

Cell Immunol. 2017 Feb;312:25-34. doi: 10.1016/j.cellimm.2016.11.006. Epub 2016 Nov 9.

9.

Immunological characterization of the aryl hydrocarbon receptor (AHR) knockout rat in the presence and absence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Phadnis-Moghe AS, Chen W, Li J, Crawford RB, Bach A, D'Ingillo S, Kovalova N, Suarez-Martinez JE, Kaplan BL, Harrill JA, Budinsky R, Rowlands JC, Thomas RS, Kaminski NE.

Toxicology. 2016 Aug 10;368-369:172-182. doi: 10.1016/j.tox.2016.08.019. Epub 2016 Aug 31.

PMID:
27590929
10.

Exposure to an environmentally relevant mixture of organochlorine compounds and polychlorinated biphenyls Promotes hepatic steatosis in male Ob/Ob mice.

Mulligan C, Kondakala S, Yang EJ, Stokes JV, Stewart JA, Kaplan BL, Howell GE 3rd.

Environ Toxicol. 2017 Apr;32(4):1399-1411. doi: 10.1002/tox.22334. Epub 2016 Aug 17.

PMID:
27533883
11.

Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors.

Simkins TJ, Fried D, Parikh K, Galligan JJ, Goudreau JL, Lookingland KJ, Kaplan BL.

J Neuroimmune Pharmacol. 2016 Dec;11(4):669-679. Epub 2016 Jun 10.

PMID:
27287619
12.

Immunomodulation By Subchronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.

Yang EJ, Stokes JV, Kummari E, Eells J, Kaplan BL.

Toxicol Sci. 2016 May;151(1):35-43. doi: 10.1093/toxsci/kfw020. Epub 2016 Jan 27.

13.

Lipopolysaccharide suppresses carboxylesterase 2g activity and 2-arachidonoylglycerol hydrolysis: A possible mechanism to regulate inflammation.

Szafran B, Borazjani A, Lee JH, Ross MK, Kaplan BL.

Prostaglandins Other Lipid Mediat. 2015 Sep;121(Pt B):199-206. doi: 10.1016/j.prostaglandins.2015.09.005. Epub 2015 Sep 25.

14.

Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.

Kaplan BL, Li J, LaPres JJ, Pruett SB, Karmaus PW.

Toxicol Sci. 2015 Jun;145(2):214-32. doi: 10.1093/toxsci/kfv060. Review.

15.

Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol.

Chen W, Crawford RB, Kaplan BL, Kaminski NE.

J Neuroimmune Pharmacol. 2015 Jun;10(2):344-55. doi: 10.1007/s11481-015-9597-x. Epub 2015 Apr 22.

PMID:
25900076
16.

Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity.

Simkins T, Crawford RB, Goudreau JL, Lookingland KJ, Kaplan BL.

J Neuroimmune Pharmacol. 2014 Sep;9(4):544-57. doi: 10.1007/s11481-014-9549-x. Epub 2014 May 29.

PMID:
24870806
17.

Induced T cell cytokine production is enhanced by engineered nanoparticles.

Chen W, Zhang Q, Kaplan BL, Baker GL, Kaminski NE.

Nanotoxicology. 2014 Aug;8 Suppl 1:11-23. doi: 10.3109/17435390.2013.848302. Epub 2013 Nov 21.

18.

Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.

Ngaotepprutaram T, Kaplan BL, Kaminski NE.

Toxicol Appl Pharmacol. 2013 Nov 15;273(1):209-18. doi: 10.1016/j.taap.2013.08.023. Epub 2013 Aug 30.

19.

Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice.

Brandenberger C, Rowley NL, Jackson-Humbles DN, Zhang Q, Bramble LA, Lewandowski RP, Wagner JG, Chen W, Kaplan BL, Kaminski NE, Baker GL, Worden RM, Harkema JR.

Part Fibre Toxicol. 2013 Jul 1;10:26. doi: 10.1186/1743-8977-10-26.

20.

Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation.

Ngaotepprutaram T, Kaplan BL, Carney S, Crawford R, Kaminski NE.

Toxicology. 2013 Aug 9;310:84-91. doi: 10.1016/j.tox.2013.05.009. Epub 2013 May 29.

21.

The role of CB1 in immune modulation by cannabinoids.

Kaplan BL.

Pharmacol Ther. 2013 Mar;137(3):365-74. doi: 10.1016/j.pharmthera.2012.12.004. Epub 2012 Dec 20. Review.

PMID:
23261520
22.

Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice.

Karmaus PW, Wagner JG, Harkema JR, Kaminski NE, Kaplan BL.

J Immunotoxicol. 2013 Jul-Sep;10(3):321-8. doi: 10.3109/1547691X.2012.741628. Epub 2012 Nov 23.

23.

Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2.

Karmaus PW, Chen W, Crawford R, Kaplan BL, Kaminski NE.

Toxicol Sci. 2013 Feb;131(2):419-33. doi: 10.1093/toxsci/kfs315. Epub 2012 Nov 14.

24.

Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120.

Chen W, Kaplan BL, Pike ST, Topper LA, Lichorobiec NR, Simmons SO, Ramabhadran R, Kaminski NE.

J Leukoc Biol. 2012 Nov;92(5):1093-102. doi: 10.1189/jlb.0212082. Epub 2012 Aug 16.

25.

Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells.

Ngaotepprutaram T, Kaplan BL, Crawford RB, Kaminski NE.

J Neuroimmune Pharmacol. 2012 Dec;7(4):969-80. doi: 10.1007/s11481-012-9390-z. Epub 2012 Aug 1.

26.
27.

Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice.

Simkins TJ, Janis KL, McClure AK, Behrouz B, Pappas SS, Lehner A, Kaminski NE, Goudreau JL, Lookingland KJ, Kaplan BL.

J Neuroimmune Pharmacol. 2012 Sep;7(3):533-8. doi: 10.1007/s11481-012-9375-y. Epub 2012 May 27.

28.

Suppression of humoral immune responses by 2,3,7,8-tetrachlorodibenzo-p-dioxin intercalated in smectite clay.

Boyd SA, Johnston CT, Pinnavaia TJ, Kaminski NE, Teppen BJ, Li H, Khan B, Crawford RB, Kovalova N, Kim SS, Shao H, Gu C, Kaplan BL.

Environ Toxicol Chem. 2011 Dec;30(12):2748-55. doi: 10.1002/etc.701.

29.

Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection.

Karmaus PW, Chen W, Crawford RB, Harkema JR, Kaplan BL, Kaminski NE.

J Leukoc Biol. 2011 Nov;90(5):983-95. doi: 10.1189/jlb.0511219. Epub 2011 Aug 26.

30.

2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells.

Lu H, Crawford RB, Kaplan BL, Kaminski NE.

Toxicol Appl Pharmacol. 2011 Sep 15;255(3):251-60. doi: 10.1016/j.taap.2011.06.026. Epub 2011 Jul 21.

31.

Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events.

Karmaus PW, Chen W, Kaplan BL, Kaminski NE.

J Neuroimmune Pharmacol. 2012 Dec;7(4):843-55. doi: 10.1007/s11481-011-9293-4. Epub 2011 Jul 26.

32.

15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma.

Raman P, Kaplan BL, Thompson JT, Vanden Heuvel JP, Kaminski NE.

Mol Pharmacol. 2011 Jul;80(1):201-9. doi: 10.1124/mol.110.070441. Epub 2011 Apr 21.

33.

TCDD adsorbed on silica as a model for TCDD contaminated soils: Evidence for suppression of humoral immunity in mice.

Kaplan BL, Crawford RB, Kovalova N, Arencibia A, Kim SS, Pinnavaia TJ, Boyd SA, Teppen BJ, Kaminski NE.

Toxicology. 2011 Apr 11;282(3):82-7. doi: 10.1016/j.tox.2011.01.013. Epub 2011 Jan 25.

34.

Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells.

Lu H, Crawford RB, Suarez-Martinez JE, Kaplan BL, Kaminski NE.

Toxicol Sci. 2010 Nov;118(1):86-97. doi: 10.1093/toxsci/kfq234. Epub 2010 Aug 11.

35.

The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin.

Kaplan BL, Lawver JE, Karmaus PW, Ngaotepprutaram T, Birmingham NP, Harkema JR, Kaminski NE.

Toxicol Pathol. 2010 Apr;38(3):382-92. doi: 10.1177/0192623310362706. Epub 2010 Feb 26.

36.

Establishment of an immunoglobulin m antibody-forming cell response model for characterizing immunotoxicity in primary human B cells.

Lu H, Crawford RB, North CM, Kaplan BL, Kaminski NE.

Toxicol Sci. 2009 Dec;112(2):363-73. doi: 10.1093/toxsci/kfp224. Epub 2009 Sep 18.

37.

Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.

Lu H, Kaplan BL, Ngaotepprutaram T, Kaminski NE.

J Leukoc Biol. 2009 Feb;85(2):322-9. doi: 10.1189/jlb.0608390. Epub 2008 Nov 6.

38.

Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.

Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE.

J Leukoc Biol. 2008 Dec;84(6):1574-84. doi: 10.1189/jlb.0508282. Epub 2008 Sep 12.

39.

The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).

Kaplan BL, Springs AE, Kaminski NE.

Biochem Pharmacol. 2008 Sep 15;76(6):726-37. doi: 10.1016/j.bcp.2008.06.022. Epub 2008 Jul 8.

40.

A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells.

Rockwell CE, Raman P, Kaplan BL, Kaminski NE.

Biochem Pharmacol. 2008 Aug 1;76(3):353-61. doi: 10.1016/j.bcp.2008.05.005. Epub 2008 May 9.

PMID:
18571623
41.

Interferon-gamma renders tumors that express low levels of Her-2/neu sensitive to cytotoxic T cells.

Kaplan BL, Norell H, Callender GG, Ohlum T, Kiessling R, Nishimura MI.

Cancer Immunol Immunother. 2006 Jun;55(6):653-62. Epub 2005 Sep 6.

PMID:
16151808
42.

A new murine tumor model for studying HLA-A2-restricted anti-tumor immunity.

Kaplan BL, Moore TV, Schreiber K, Callender GG, Schreiber H, Nishimura MI.

Cancer Lett. 2005 Jun 16;224(1):153-66. Epub 2004 Dec 25.

PMID:
15911111
43.

Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.

Kaplan BL, Ouyang Y, Herring A, Yea SS, Razdan R, Kaminski NE.

Toxicol Appl Pharmacol. 2005 Jun 1;205(2):107-15. Epub 2005 Jan 1.

PMID:
15893538
44.

2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.

Kaplan BL, Ouyang Y, Rockwell CE, Rao GK, Kaminski NE.

J Leukoc Biol. 2005 Jun;77(6):966-74. Epub 2005 Mar 17.

PMID:
15774549
45.

Thromboprophylaxis in surgical patients.

Bick RL, Kaplan BL.

Eur J Med Res. 2004 Mar 30;9(3):104-11. Review.

PMID:
15096319
46.

Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes.

Kaplan BL, Rockwell CE, Kaminski NE.

J Pharmacol Exp Ther. 2003 Sep;306(3):1077-85. Epub 2003 Jun 12.

PMID:
12805480
47.

Redirecting T lymphocyte specificity using T cell receptor genes.

Kaplan BL, Yu DC, Clay TM, Nishimura MI.

Int Rev Immunol. 2003 May-Aug;22(3-4):229-53. Review.

PMID:
12745641
48.

Evoked potential monitoring during aneurysm operation: observations after fifty cases.

Friedman WA, Kaplan BL, Day AL, Sypert GW, Curran MT.

Neurosurgery. 1987 May;20(5):678-87.

PMID:
3601013
49.

Systemic sporotrichosis polytenosynovitis with median and ulnar nerve entrapment.

Atdjian M, Granda JL, Ingberg HO, Kaplan BL.

JAMA. 1980 May 9;243(18):1841-2. No abstract available.

PMID:
7365961
50.

[Method of uniform measurement of the degree of cellular polymorphism in the early diagnosis of cancer].

Kaplan BL, Kozlenko MD.

Sov Med. 1978 Oct;(10):83-6. Russian. No abstract available.

PMID:
715541

Supplemental Content

Loading ...
Support Center